Clinical trial
Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana
NCT00403117 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00403117 |
|---|---|
| Title | Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana |
| Official title | Opioid Antagonism Enhances Marijuana's Effects in Heavy Marijuana Smokers |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | Research Foundation for Mental Hygiene, Inc. National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Marijuana Use |
| Intervention type | Drug |
| Interventions | Placebo + Inactive Marijuana (0% THC), Placebo + Active Marijuana (3.27% THC), Naltrexone 12 Mg+ Active Marijuana (3.27% THC), Naltrexone 25 Mg + Active Marijuana (3.27% THC), Naltrexone 50 Mg+ Active Marijuana (3.27% THC), Naltrexone 100 Mg+ Active Marijuana (3.27% THC), Naltrexone 12 Mg + Inactive Marijuana (0% THC), Naltrexone 25 Mg + Inactive Marijuana (0% THC), Naltrexone 50 Mg + Inactive Marijuana (0% THC), Naltrexone 100 Mg + Inactive Marijuana (0% THC) |
| Enrollment | 49 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Aug 1, 2010 |
| First posted | Nov 23, 2006 |
| Last update posted | Mar 15, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: